Self-powered elastic Conductors based on thermoelectric materials with the ability to harvest energy from the living environment are considered as important for electronic devices under off-grid, maintenance-free, or unfeasible battery replacement circumstances. Poly(3,4-ethylenedioxythiophene)-poly-(styrenesulfonate) (PEDOT:PSS) is perhaps the most well-known organic conductor. However, the application of PEDOT:PSS in flexible devices is limited by its brittleness and various unrecoverable properties under strain. Various polymer blends based on water-soluble polymers and PEDOT:PSS have been prepared. Nevertheless, they fail to illustrate good balance between electrical conductivity and mechanical performance due to various issues, including the phase morphology with PEDOT:PSS as the dispersed phase; thus, the formation of a conductive network between PEDOT:PSS is prohibited. In this study, PEDOT:PSS is incorporated into natural rubber (NR), with NR as the dispersed phase. For 10 wt % PEDOT:PSS−NR composite films doped with dimethyl sulfoxide (DMSO), the conductivity was up to 87 S/cm and the elongation at break was maintained at 490%. More importantly, self-powered temperature-and tensile strain-sensing abilities were also realized. Furthermore, it is also demonstrated that most of the unrecoverable strain and conductivity under cyclic tensile strain could be healed by water and phosphate-buffered saline (PBS) post-treatment. This work provides interesting insights for preparing healed and stretchable self-powered electronic sensors.

Background/Aims: Breast cancer is a common cause of cancer mortality throughout the world. The cross-talk between cancer cells and interstitial cells exerts significant effects on neoplasia and tumor development and is modulated in part by chemokines. CXC is one of four chemokine families involved in mediating survival, angiogenesis, and immunosensitization by chemoattracting leukocytes, and it incentivizes tumor cell growth, invasion and metastasis in the tumor microenvironment. However, the differential expression profiles and prognostic values of these chemokines remains to be elucidated. Methods: In this study, we compared transcriptional CXC chemokines and survival data of patients with breast carcinoma (BC) using the ONCOMINE dataset, Kaplan-Meier Plotter, TCGA and cBioPortal. Results: We discovered increased mRNA levels for CXCL8/10/11/16/17, whereas mRNA expression of CXCL1/2/3/4/5/6/7/12/14 was lower in BC patients compared to non-tumor tissues. Kaplan-Meier plots revealed that high mRNA levels of CXCL1/2/3/4/5/6/7/12/14 correlate with relapse-free survival (RFS) in all types of BC patients. Conversely, high CXCL8/10/11 predicted worse RFS in BC patients. Significantly, high transcription levels of CXCL9/12/13/14 conferred an overall survival (OS) advantage in BC patients, while high levels of CXCL8 demonstrated shorter OS in all BC sufferers. Conclusions: Integrative bioinformatics analysis suggests that CXCL8/12/14 are potential suitable targets for precision therapy in BC patients compared to other CXC chemokines.

This study was supported by the National Natural Science Foundation of China (81170570, G.J.Y. 81370683, G.J.Y. 81501251, Y.J. 31571189, H.X.S. and 81571402, G.J.Y.), and a special grant for clinical medicine science of Jiangsu Province (BL2014003, H.X.S.). The authors have no conflicts of interest to declare.